Description
Clinical-stage biotechnology company focusing on the development of cutting edge, virus-driven immunotherapies for difficult-to-treat cancers. 15 granted patents protecting the intellectual property behind drugs and Immunotherapy process in the U.S, Canada, Europe and Asia. Heavily Differentiated and patented Immunology approach with progressive drugs. Significant cash flow potential both internally and through out-licensing products.
Documents
Auction Information
Due Diligence Information
* Requires confirmation of Online Agreement
Terms & Conditions
- Buyers Premium:
NA (see Bidding Procedures)
- Closing:
Later of (i) 30-days of Auction; and (ii) 15 days after Court approval. See Bidding Procedures.
- Deposit Amount:
10% of Bid Amount. See Bidding Procedures.
- Broker Co-op:
NA
Inspections
Qualifying Bid Deadline: November 17, 2023 @ 12:00 PM ET
Documents
Auction Information
Due Diligence Information
* Requires confirmation of Online Agreement
Terms & Conditions
- Buyers Premium:
NA (see Bidding Procedures)
- Closing:
Later of (i) 30-days of Auction; and (ii) 15 days after Court approval. See Bidding Procedures.
- Deposit Amount:
10% of Bid Amount. See Bidding Procedures.
- Broker Co-op:
NA
Inspections
Qualifying Bid Deadline: November 17, 2023 @ 12:00 PM ET